98 related articles for article (PubMed ID: 10161259)
1. Falsely low calcium measurements after high volume plasma exchange in a patient with liver failure.
Miller JP; Mintz PD
Transfus Sci; 1994 Sep; 15(3):299-302. PubMed ID: 10161259
[TBL] [Abstract][Full Text] [Related]
2. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.
McKenzie R; Fried MW; Sallie R; Conjeevaram H; Di Bisceglie AM; Park Y; Savarese B; Kleiner D; Tsokos M; Luciano C
N Engl J Med; 1995 Oct; 333(17):1099-105. PubMed ID: 7565947
[TBL] [Abstract][Full Text] [Related]
3. Impairment of citrate metabolism in acute hepatic failure.
Apsner R; Schwarzenhofer M; Derfler K; Zauner C; Ratheiser K; Kranz A
Wien Klin Wochenschr; 1997 Feb; 109(4):123-7. PubMed ID: 9076929
[TBL] [Abstract][Full Text] [Related]
4. Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment.
Yu JW; Sun LJ; Zhao YH; Li SC
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1242-9. PubMed ID: 18637053
[TBL] [Abstract][Full Text] [Related]
5. Study of plasma exchange for liver failure: beneficial and harmful effects.
Abe T; Kobata H; Hanba Y; Kitabata Y; Narukawa N; Hasegawa H; Abe T; Fukagawa M
Ther Apher Dial; 2004 Jun; 8(3):180-4. PubMed ID: 15154867
[TBL] [Abstract][Full Text] [Related]
6. Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function.
Lange CM; Bojunga J; Hofmann WP; Wunder K; Mihm U; Zeuzem S; Sarrazin C
Hepatology; 2009 Dec; 50(6):2001-6. PubMed ID: 19937695
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection.
Tennant BC; Baldwin BH; Graham LA; Ascenzi MA; Hornbuckle WE; Rowland PH; Tochkov IA; Yeager AE; Erb HN; Colacino JM; Lopez C; Engelhardt JA; Bowsher RR; Richardson FC; Lewis W; Cote PJ; Korba BE; Gerin JL
Hepatology; 1998 Jul; 28(1):179-91. PubMed ID: 9657111
[TBL] [Abstract][Full Text] [Related]
8. Effects of fialuridine on hepatitis B immune globulin pharmacokinetics following orthotopic liver transplant for chronic hepatitis B viral-induced cirrhosis.
McGory RW; Ishitani MB; Oliveira WM; Stevenson WC; Dickson RC; Caldwell SH; Pruett TL
Transplant Proc; 1995 Feb; 27(1):1213-4. PubMed ID: 7878854
[No Abstract] [Full Text] [Related]
9. Extracorporeal blood purification in the management of patients with hepatic failure.
Kaplan AA; Epstein M
Semin Nephrol; 1997 Nov; 17(6):576-82. PubMed ID: 9353867
[TBL] [Abstract][Full Text] [Related]
10. Citrate anticoagulation during plasma exchange in a patient with thrombotic thrombocytopenic purpura: short heparin-free hemodialysis helps to attenuate citrate load.
Buturović-Ponikvar J; Pernat AM; Ponikvar R
Ther Apher Dial; 2005 Jun; 9(3):258-61. PubMed ID: 15967002
[TBL] [Abstract][Full Text] [Related]
11. Deaths in US fialuridine trial.
Brahams D
Lancet; 1994 Jun; 343(8911):1494-5. PubMed ID: 7911188
[No Abstract] [Full Text] [Related]
12. Prediction value of model for end-stage liver disease scoring system on prognosis in the acute on chronic liver failure patients with plasma exchange treatment.
Mao W; Ye B; Lin S; Fu Y; Chen Y; Chen Y
ASAIO J; 2010; 56(5):475-8. PubMed ID: 20613491
[TBL] [Abstract][Full Text] [Related]
13. Clinical course of four patients receiving the experimental antiviral agent fialuridine for the treatment of chronic hepatitis B infection.
Stevenson W; Gaffey M; Ishitani M; McCullough C; Dickson R; Caldwell S; Lobo P; Pruett T
Transplant Proc; 1995 Feb; 27(1):1219-21. PubMed ID: 7878856
[No Abstract] [Full Text] [Related]
14. Adjuvant therapeutic plasma exchange in liver failure: assessments of clinical and laboratory parameters.
Bektas M; Idilman R; Soykan I; Soydan E; Arat M; Cinar K; Coban S; Tuzun A; Bozkaya H; Ormeci N; Ozden A
J Clin Gastroenterol; 2008; 42(5):517-21. PubMed ID: 18344887
[TBL] [Abstract][Full Text] [Related]
15. Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration.
Hetzel GR; Taskaya G; Sucker C; Hennersdorf M; Grabensee B; Schmitz M
Am J Kidney Dis; 2006 Nov; 48(5):806-11. PubMed ID: 17060000
[TBL] [Abstract][Full Text] [Related]
16. Severe hypercalcemia following neonatal liver transplantation.
Bartosh SM; Sprague SM; Nakagawa Y; Baron BW; Aronson AJ
Miner Electrolyte Metab; 1995; 21(6):428-30. PubMed ID: 8592488
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B and liver transplantation.
Tung BY; Kowdley KV
Clin Infect Dis; 2005 Nov; 41(10):1461-6. PubMed ID: 16231258
[TBL] [Abstract][Full Text] [Related]
18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial toxicity--new adverse drug effects.
Swartz MN
N Engl J Med; 1995 Oct; 333(17):1146-8. PubMed ID: 7565955
[No Abstract] [Full Text] [Related]
20. Histopathologic changes associated with fialuridine hepatotoxicity.
Kleiner DE; Gaffey MJ; Sallie R; Tsokos M; Nichols L; McKenzie R; Straus SE; Hoofnagle JH
Mod Pathol; 1997 Mar; 10(3):192-9. PubMed ID: 9071726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
